A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India

Background: To assess safety and tolerability of a diphtheria and tetanus toxoid, acellular pertussis, inactivated poliovirus and Haemophilus influenza type B conjugate adsorbed vaccine (DTaP-IPV + Hib), manufactured by Serum Institute of India Pvt. Ltd. (SIIPL)’s, the current first-in-human Phase 1...

Full description

Bibliographic Details

Published in:	Vaccine: X
Main Authors:	Hitt Sharma, Kiran Marthak, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Akash Patel, Harish Rao, Sunil Gairola, Umesh Shaligram
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Subjects:	DTaP-IPV+Hib vaccine Phase 1 Clinical trial Safety Tolerability
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590136223000414